Health
Experimental Vaccine Shows Promise Against Brain Cancer
An experimental vaccine, SurVaxM, extended survival in younger glioblastoma patients, though it narrowly missed its overall trial goal.
—7 min read
Tag
4 articles
An experimental vaccine, SurVaxM, extended survival in younger glioblastoma patients, though it narrowly missed its overall trial goal.
A single CRISPR infusion reduced LDL cholesterol and triglycerides for a year in a small trial, offering hope for one-time heart disease treatment.
Biogen's diranersen targeting tau protein shows cognitive benefits in Phase 2 Alzheimer's trial, offering a new pathway beyond amyloid.
A new experimental pill nearly doubles survival for advanced pancreatic cancer patients, targeting the long-undruggable KRAS mutation.